Top Markets
Coin of the day
Alseres Pharmaceuticals, Inc. Alseres Pharmaceuticals, Inc.

Alseres Pharmaceuticals, Inc.

ALSE
Pozycja w akcjach #42806
Alseres Pharmaceuticals, Inc. focuses on creating both diagnostic and... Alseres Pharmaceuticals, Inc. focuses on creating both diagnostic and therapeutic solutions, with a primary emphasis on ailments affecting the central nervous system. Their flagship experimental compound is Altropane, a molecular imaging agent developed for identifying and diagnosing Parkinson's disease and dementia. Founded in 1972, the company was previously known as Boston Life Sciences, Inc. before officially changing its name to Alseres Pharmaceuticals, Inc. in June 2007. Its operations are headquartered in Auburndale, Massachusetts.
Cena akcji
$0.01
Ostatnia synchronizacja: 2024-08-19
Kapitalizacja rynkowa
$61.27
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
0.00%
Kraj
US
Handel Alseres Pharmaceuticals, Inc. (ALSE)

Kategoria

Historia ceny akcji dla Alseres Pharmaceuticals, Inc. (ALSE)
Najwyższa cena zamknięcia: $0.01 dnia 2024-08-01

Najniższa cena zamknięcia: $29.96K dnia 1994-12-01
Historia cen akcji firmy Alseres Pharmaceuticals, Inc. od 1994 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2024 0.00%
2023 0.00%
2022 0.00%
2021 -99.83%
2020 -40.00%
2019 -33.33%
2018 -62.96%
2017 -19.00%
2016 -23.08%
2015 -68.82%
2014 23.30%
2013 87.23%
2012 -43.51%
2011 -82.93%
2010 -26.51%
2009 -84.07%
2008 -44.14%
2007 15.21%
2006 17.90%
2005 -30.46%
2004 -53.37%
2003 1.22%
2002 -55.80%
2001 -22.03%
2000 -4.11%
1999 4.07%
1998 65.57%
1997 -66.23%
1996 -2.51%
1995 471.92%
1994 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$527.87 33.33%
US
$873.57 35.10%
NL
$736.38 7.69%
CH
$263.09 18.09%
BE
$1.07K -7.57%
KR